GBE50 Attenuates Inflammatory Response by Inhibiting the p38 MAPK and NF-κB Pathways in LPS-Stimulated Microglial Cells
Figure 1
The effect of GBE50 on viability of BV2 cells. (a) The effect of various GBE50 concentrations on BV2 cell viability. No significant difference was observed (). (b) The effect of different concentrations of GBE50 on BV2 cell viability activated by LPS. No significant difference was observed ().
